Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis.

@article{Akl2008LowmolecularweightHV,
  title={Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis.},
  author={Elie A. Akl and Irene Terrenato and Maddalena Barba and Francesca Sperati and Elena V Sempos and Paola Muti and Deborah J Cook and Holger J. Sch{\"u}nemann},
  journal={Archives of internal medicine},
  year={2008},
  volume={168 12},
  pages={1261-9}
}
BACKGROUND The relative benefits and harms of low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH) are required for judgments regarding the appropriate perioperative thromboprophylaxis in patients with cancer. We systematically reviewed the literature to quantify these effects. METHODS The comprehensive searches included (1) an electronic search of MEDLINE, EMBASE, ISI the Web of Science, and CENTRAL (The Cochrane Central Register of Controlled Trials); (2) a hand search of… CONTINUE READING